High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
- Citation:
- Leuk Lymphoma vol 48 (5) 870-80
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA02599, CA03927, CA04326, CA04457, CA08025, CA12499, CA16450, CA21060, CA26806, CA31946, CA31983, CA32291, CA33601, CA35279, CA41287, CA47555, CA47559, CA47575, CA47577, CA47642, CA60138, CA77440
- Corr. Author:
- Authors:
- Bruce A Peterson Jeffrey Johnson Margaret A Shipp Maurice Barcos Jon P Gockerman George P Canellos
- Networks:
- Study
- CALGB-9351
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Female, Granulocyte Colony-Stimulating Factor, Humans, Lymphoma, Non-Hodgkin, Male, Middle Aged, Prednisone, Prognosis, Recurrence, Time Factors, Treatment Outcome, Vincristine